Regulation and Practice of Human Tissue Research in the UK

この論文にアクセスする

この論文をさがす

著者

抄録

The use of human tissue in drug discovery and development is now well accepted, however, its use for experimental purposes is still restricted not only by practical, but also by ethical and legal constraints. The UK government, through its Human Tissue Act 2004, is leading the way in establishing clear ethical and legal guidelines that will both facilitate and regulate the process. It has also set up a Human Tissue Authority, whose task is to establish codes of practice to regulate all aspects of the Act. The Act emphasises donor anonymisation, freely given informed consent, independent ethical review and the licensing of tissue banks. The UK's approach could serve as a model for this important, but still contentious, area of activity worldwide. With the expansion of the availability of human tissue for research, it will undoubtedly eventually become a mandatory part of the regulatory filing for new drugs. This may well first be seen in the testing of cross reactivity of new therapeutic antibodies, for which the FDA has already identified a set of tissues against which they are to be tested. It is timely therefore that the development of frozen tissue microarrays looks to make this a simple and routine operation.

収録刊行物

  • Alternatives to animal testing and experimentation : AATEX  

    Alternatives to animal testing and experimentation : AATEX 11(3), 162-169, 2006-03-30 

    Japanese Society for Alternative to Animal Experiments

参考文献:  24件

参考文献を見るにはログインが必要です。ユーザIDをお持ちでない方は新規登録してください。

各種コード

  • NII論文ID(NAID)
    10021094767
  • NII書誌ID(NCID)
    AA11161787
  • 本文言語コード
    ENG
  • 資料種別
    REV
  • ISSN
    13440411
  • データ提供元
    CJP書誌  J-STAGE 
ページトップへ